Results 281 to 290 of about 86,728 (368)

Insights into ALS‐inhibiting herbicide resistance in Poa annua in an arable cropping system

Pest Management Science, Volume 81, Issue 12, Page 8128-8136, December 2025.
Variable cross‐resistance to ALS inhibitors in five Poa annua populations from wheat fields in Ireland caused by different TSR mutations. Abstract BACKGROUND Dependence on a single herbicide type to control a broad‐spectrum of weeds has resulted in cases of resistance to acetolactate synthase (ALS) inhibitors in weeds normally considered lower priority
Alwarnaidu Vijayarajan Vijaya Bhaskar, Iniya Vijayakumar, Joel Torra, Fabian Runge, Michael Hennessy, Patrick Dermot Forristal   +5 more
wiley   +1 more source

Acetyl-CoA carboxylase inhibition increases retinal pigment epithelial cell fatty acid flux and restricts apolipoprotein efflux. [PDF]

J Biol Chem
Hass DT, Pandey K, Engel A, Horton N, Haydinger CD, Robbings BM, Lim RR, Sadilek M, Zhang Q, Gulette GA, Li A, Xu L, Miller JML, Chao JR, Hurley JB.   +14 more
europepmc   +1 more source

Screening for Dimerization Inhibitors for Bacterial Acetyl CoA Carboxylase

, 2019
Michael S. Kent, Kenneth L. Sale, James Ricken, Daniella Martinez, Miranda Juarros, Grover Walrdop   +5 more
openalex   +1 more source

Multi‐omic data integration and exploiting metabolic models using systems biology approach increase precision in subtyping and early diagnosis of cancer

Quantitative Biology, Volume 13, Issue 4, December 2025.
Abstract Cancer is a complex and heterogeneous disease characterized by various genetic and epigenetic alterations. Early diagnosis, accurate subtyping, and staging are essential for effective, personalized treatment and improved survival rates. Traditional diagnostic methods, such as biopsies, are invasive and carry operational risks that hinder ...
Ezgi Tanıl, Emrah Nikerel
wiley   +1 more source

Probing the allosteric activation of pyruvate carboxylase using 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate as a fluorescent mimic of the allosteric activator acetyl CoA

, 2011
Abdussalam Adina-Zada, Rasmani Hazra, Chutima Sereeruk, Sarawut Jitrapakdee, Tonya N. Zeczycki, Martin St. Maurice, W. W. Cleland, John C. Wallace, Paul V. Attwood   +8 more
openalex   +2 more sources

Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.

Cancer Letters, 2017
Jingtao Luo, Yun Hong, Yang Lu, Songbo Qiu, B. Chaganty, Lun Zhang, Xudong Wang, Qiang Li, Z. Fan   +8 more
semanticscholar   +1 more source

Targets and strategies to design soybean seed composition traits

The Plant Genome, Volume 18, Issue 4, December 2025.
Abstract Breeders and geneticists have put great effort into enhancing soybean seed composition and developing elite varieties with desired traits. However, diverse end‐uses and changing consumer preferences present new challenges and opportunities to develop desired compositional profiles for the market.
Ritesh Kumar, Steven Mulkey, Rahul Mahadev Shelake, Rachel Combs‐Giroir, Thiya Mukherjee, Doug K. Allen, Tom Elmo Clemente, Minviluz G. Stacey, Aaron J. Lorenz, Robert M. Stupar   +9 more
wiley   +1 more source

Correction for Chen et al., "Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination". [PDF]

Antimicrob Agents Chemother
Chen T, Yao J, Quan K, Xu J, Hang X, Tong Q, Liu G, Luo P, Zeng L, Feng G, Bi H.   +10 more
europepmc   +1 more source

Disruption of de novo fatty acid synthesis via acetyl‐CoA carboxylase 1 inhibition prevents acute graft‐versus‐host disease

European Journal of Immunology, 2016
Solaiman Raha, Brenda Raud, Linda Oberdörfer, C. N. Castro, A. Schreder, J. Freitag, T. Longerich, M. Lochner, T. Sparwasser, L. Berod, C. Koenecke, I. Prinz   +11 more
semanticscholar   +1 more source

Microbial and Metabolic Disorders in Cervical Cancer: Structural Insights, Biomarkers, Mechanisms, and Therapeutic Strategies

Cancer Science, Volume 116, Issue 12, Page 3228-3238, December 2025.
We unravel synergistic mechanisms by which microbial‐host metabolic networks regulate the tumor immune microenvironment and therapy resistance, bridging gaps between microbiota research and cancer metabolism. Identified biomarkers (e.g., Lactobacillus, C8‐ceramide‐1‐phosphate) and therapeutic approaches (e.g., FMT combined with immune checkpoint ...
Hong Tao, Luyu Wang, Yi Ding, Lixian Yi, Mutian Han, Mengmeng Gu, Jian Wu   +6 more
wiley   +1 more source